Ex vivo gene transfer and correction for cell-based therapies

Research output: Contribution to journalArticle

238 Citations (Scopus)

Abstract

Cell-based therapies are fast-growing forms of personalized medicine that make use of the steady advances in stem cell manipulation and gene transfer technologies. In this Review, I highlight the latest developments and the crucial challenges for this field, with an emphasis on haematopoietic stem cell gene therapy, which is taken as a representative example given its advanced clinical translation. New technologies for gene correction and targeted integration promise to overcome some of the main hurdles that have long prevented progress in this field. As these approaches marry with our growing capacity for genetic reprogramming of mammalian cells, they may fulfil the promise of safe and effective therapies for currently untreatable diseases.

Original languageEnglish
Pages (from-to)301-315
Number of pages15
JournalNature Reviews Genetics
Volume12
Issue number5
DOIs
Publication statusPublished - May 2011

Fingerprint

Cell- and Tissue-Based Therapy
Targeted Gene Repair
Technology Transfer
Precision Medicine
Hematopoietic Stem Cells
Genetic Therapy
Genes
Stem Cells
Technology
Therapeutics
Cellular Reprogramming

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Ex vivo gene transfer and correction for cell-based therapies. / Naldini, Luigi.

In: Nature Reviews Genetics, Vol. 12, No. 5, 05.2011, p. 301-315.

Research output: Contribution to journalArticle

@article{b208d2b30960400283298850da04244e,
title = "Ex vivo gene transfer and correction for cell-based therapies",
abstract = "Cell-based therapies are fast-growing forms of personalized medicine that make use of the steady advances in stem cell manipulation and gene transfer technologies. In this Review, I highlight the latest developments and the crucial challenges for this field, with an emphasis on haematopoietic stem cell gene therapy, which is taken as a representative example given its advanced clinical translation. New technologies for gene correction and targeted integration promise to overcome some of the main hurdles that have long prevented progress in this field. As these approaches marry with our growing capacity for genetic reprogramming of mammalian cells, they may fulfil the promise of safe and effective therapies for currently untreatable diseases.",
author = "Luigi Naldini",
year = "2011",
month = "5",
doi = "10.1038/nrg2985",
language = "English",
volume = "12",
pages = "301--315",
journal = "Nature Reviews Genetics",
issn = "1471-0056",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Ex vivo gene transfer and correction for cell-based therapies

AU - Naldini, Luigi

PY - 2011/5

Y1 - 2011/5

N2 - Cell-based therapies are fast-growing forms of personalized medicine that make use of the steady advances in stem cell manipulation and gene transfer technologies. In this Review, I highlight the latest developments and the crucial challenges for this field, with an emphasis on haematopoietic stem cell gene therapy, which is taken as a representative example given its advanced clinical translation. New technologies for gene correction and targeted integration promise to overcome some of the main hurdles that have long prevented progress in this field. As these approaches marry with our growing capacity for genetic reprogramming of mammalian cells, they may fulfil the promise of safe and effective therapies for currently untreatable diseases.

AB - Cell-based therapies are fast-growing forms of personalized medicine that make use of the steady advances in stem cell manipulation and gene transfer technologies. In this Review, I highlight the latest developments and the crucial challenges for this field, with an emphasis on haematopoietic stem cell gene therapy, which is taken as a representative example given its advanced clinical translation. New technologies for gene correction and targeted integration promise to overcome some of the main hurdles that have long prevented progress in this field. As these approaches marry with our growing capacity for genetic reprogramming of mammalian cells, they may fulfil the promise of safe and effective therapies for currently untreatable diseases.

UR - http://www.scopus.com/inward/record.url?scp=79954692758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954692758&partnerID=8YFLogxK

U2 - 10.1038/nrg2985

DO - 10.1038/nrg2985

M3 - Article

C2 - 21445084

AN - SCOPUS:79954692758

VL - 12

SP - 301

EP - 315

JO - Nature Reviews Genetics

JF - Nature Reviews Genetics

SN - 1471-0056

IS - 5

ER -